Krystal Biotech (KRYS) Change in Cash (2016 - 2026)

Krystal Biotech has disclosed Change in Cash across 11 years of filings, most recently posting $5.0 million for Q1 2026.

• Change in Cash for Q1 2026 came in at $5.0 million, up 113.88% year-over-year; the trailing twelve-month figure through Mar 2026 was $192.5 million (up 483.28% YoY), and the FY2025 annual result was $151.4 million, up 1224.85% from the prior year.
• Change in Cash came in at $5.0 million for Q1 2026 at Krystal Biotech, down from $103.7 million in the prior quarter.
• In the past five years, Change in Cash ranged from a high of $135.1 million in Q2 2023 to a low of -$71.9 million in Q1 2022.
• The 5-year median for Change in Cash is -$13.2 million (2024), against an average of $9.4 million.
• Peak annual rise in Change in Cash reached 456.35% in 2025, while the deepest fall reached 5423.75% in 2025.
• Krystal Biotech's Change in Cash stood at -$24.5 million in 2022, then surged by 39.15% to -$14.9 million in 2023, then tumbled by 95.14% to -$29.1 million in 2024, then soared by 456.35% to $103.7 million in 2025, then plunged by 95.17% to $5.0 million in 2026.
• The last three Change in Cash figures came in at $5.0 million (Q1 2026), $103.7 million (Q4 2025), and $38.8 million (Q3 2025), per Business Quant data.